Pre-market Equity Watch on Health Care Equipment Industry - St. Jude Medical, ResMed, Accuray, Boston Scientific, and Zimmer Holdings
Editor Note: For more information about this release, please scroll to bottom.
LONDON, September 22, 2014 /PRNewswire/ --
On Friday, September 19, 2014, the NASDAQ Composite ended at 4,579.79, down 0.30%, the Dow Jones Industrial Average advanced 0.08%, to finish the day at 17,279.74, and the S&P 500 closed at 2,010.40, down 0.05%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 751.48, up 0.10%, and the index has advanced 6.95% in the previous three months. Investor-Edge has initiated coverage on the following equities: St Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Accuray Inc. (NASDAQ: ARAY), Boston Scientific Corporation (NYSE: BSX), and Zimmer Holdings Inc. (NYSE: ZMH). Free research on these five companies can be accessed at:
http://investor-edge.com/register
On Friday, shares in St Jude Medical Inc. fluctuated between $62.19 and $63.88 before ending the session 1.92% lower at $62.24. The stock reported a trading volume of 2.02 million shares, above its three months average volume of 1.55 million shares. Shares of the company traded at a PE ratio of 16.39. St Jude Medical Inc.'s shares have lost 0.83% in the previous three trading sessions and 3.58% in the last one month. However, the stock has edged 0.47% higher on YTD basis. The company's stock is trading below its 50-day and 200-day moving averages of $65.23 and $64.75, respectively. Moreover, shares of St Jude Medical Inc. have a Relative Strength Index (RSI) of 33.71. Sign up and read the free notes on STJ at:
www.Investor-Edge.com/STJ-22Sep2014
ResMed Inc.'s stock edged 0.56% lower, to close the day at $51.29. The stock recorded a trading volume of 0.86 million shares, close to its three months average volume of 0.85 million shares. The stock oscillated between $51.24 and $52.02 during the session. Over the last one month and over the past three months, ResMed Inc.'s shares have fallen by 0.89% and 0.49%, respectively. However, the stock has advanced 8.94% since the start of this year. The stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $51.24 is above its 200-day moving average of $48.30. Additionally, ResMed Inc. traded at a PE ratio of 21.14 and has an RSI of 40.68. The complimentary notes on RMD can be downloaded as in PDF format at:
www.Investor-Edge.com/RMD-22Sep2014
On Friday, shares in Accuray Inc. recorded a trading volume of 0.87 million shares, higher than its three months average volume of 0.75 million shares. The stock ended the day at $7.95, which was 1.85% below its previous day's closing of $8.10, and registered an intraday range of $7.85 and $8.14. Accuray Inc.'s shares have declined 3.28% in the previous three trading sessions, 1.85% in the last one month and 8.62% on YTD basis. The shares trading below its 50-day and 200-day moving averages of $8.08 and $8.73, respectively. Furthermore, shares of Accuray Inc. have an RSI of 45.27. Register for free on Investor-Edge and access the latest research on ARAY at:
www.Investor-Edge.com/ARAY-22Sep2014
Boston Scientific Corp.'s stock edged 0.08% lower, to close Friday's session at $12.41, after oscillating between $12.28 and $12.51. The stock recorded a trading volume of 10.68 million shares, below its three months average volume of 10.88 million shares. Over the previous three trading sessions and since the beginning of 2014, Boston Scientific Corp.'s shares have advanced 0.57% and 3.24%, respectively. However, the stock has declined 1.97% in the last one month. The stock is trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $12.82 is above its 50-day moving average of $12.60. Further, Boston Scientific Corp.'s stock traded at a PE ratio of 30.07 and has an RSI of 48.43. The complete research on BSX is available for free at:
www.Investor-Edge.com/BSX-22Sep2014
Zimmer Holdings Inc.'s stock finished Friday's session 0.25% lower at $103.99. A total of 1.24 million shares were traded, which was above its three months average volume of 1.17 million shares. The stock moved between $103.50 and $104.92 during the session. Although, Zimmer Holdings Inc.'s shares have declined 0.91% in the previous three trading sessions, it has advanced 3.35% in the last one month and 11.59% on YTD basis. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $100.78 is greater than its 200-day moving average of $98.19. Zimmer Holdings Inc.'s stock traded at a PE ratio of 18.65 and has an RSI of 60.88. Free in depth research on ZMH is available at:
www.Investor-Edge.com/ZMH-22Sep2014
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article